Reg. no. 5591757942 · Wholesale of pharmaceutical and medical goods · STOCKHOLM
Noviral Sweden AB is registered with the legal form Limited company, is based in STOCKHOLM and is active in Wholesale of pharmaceutical and medical goods. Revenue for 2022 was 12.4 MSEK.
Fiscal year ending 2022-12-31 · Amounts in SEK
Net revenue
12.4 MSEK
▼ −82%Operating result
-5.8 MSEK
▼ −145%Net result
-2.9 MSEK
▼ −126%Employees (annual report)
3
▼ −40%Total assets
4.8 MSEK
Equity
2.4 MSEK
Equity ratio
49.5 %
Profit margin
−23.5 %
MSEK
Noviral Sweden AB posted a loss in 2022: the net result was -2.9 MSEK, against 11.2 MSEK the period before. In 2022, net sales decreased 81.8 % to 12.4 MSEK. Noviral Sweden AB reported an operating margin of -46.6 % in 2022, down from 18.7 %. Net sales per employee were roughly 4.1 MSEK in 2022, with 3 employees.
Calculated by ArkivNord from filed annual reports. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2022-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
Noviral Sweden AB's reg. no. is 5591757942.
Noviral Sweden AB reported revenue of 12.4 MSEK for the fiscal year 2022.
No — Noviral Sweden AB reported a net result of -2.9 MSEK for 2022.
Noviral Sweden AB had 3 employees as of the most recently reported period (2022).
Noviral Sweden AB is registered under Wholesale of pharmaceutical and medical goods.
Noviral Sweden AB is based in STOCKHOLM.
arkivnord